Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 17Unknown 8Recruiting 8Active not recruiting 6Terminated 3Withdrawn 2Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 492Pancreatic Neoplasms 387Carcinoma, Hepatocellular 261Colonic Neoplasms 214Stomach Neoplasms 200Rectal Neoplasms 190Esophageal Neoplasms 157Neoplasms 139Carcinoma, Non-Small-Cell Lung 133Liver Neoplasms 129Neoplasm Metastasis 124Breast Neoplasms 102Cholangiocarcinoma 94Melanoma 85Ovarian Neoplasms 79Lung Neoplasms 72Squamous Cell Carcinoma of Head and Neck 57Carcinoma, Renal Cell 57Gastrointestinal Neoplasms 55Sarcoma 46Biliary Tract Neoplasms 39Prostatic Neoplasms 36Head and Neck Neoplasms 36Esophageal Squamous Cell Carcinoma 36Adenocarcinoma Of Esophagus 36Urinary Bladder Neoplasms 33Adenocarcinoma 33Uterine Cervical Neoplasms 31Triple Negative Breast Neoplasms 31Gastrointestinal Stromal Tumors 31

Interventions

indusatumab 1Cetuximab 1Anesthesia, General 1Anesthesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Pancreatic Adenocarcinoma × Gastrointestinal × Clear all
NCT04992507 2025-07-10

Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study

Ohio State University Comprehensive Cancer Center

Phase 2 Terminated
8 enrolled 7 charts
Gastrointestinal

Pancreatic Adenocarcinoma

NCT02736578 2019-06-25

Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery

Stanford University

Phase 2 Terminated
8 enrolled 16 charts
Gastrointestinal

Pancreatic Adenocarcinoma

NCT02202785 2017-05-15

A Study of MLN0264 in Patients With Pancreatic Cancer

Takeda

Phase 2 Terminated
43 enrolled 22 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡